196 related articles for article (PubMed ID: 21881595)
21. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
[TBL] [Abstract][Full Text] [Related]
22. Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.
Pearce L; Morgan L; Lin TT; Hewamana S; Matthews RJ; Deaglio S; Rowntree C; Fegan C; Pepper C; Brennan P
Haematologica; 2010 Mar; 95(3):514-7. PubMed ID: 20207849
[TBL] [Abstract][Full Text] [Related]
23. miR-15 and miR-16 induce apoptosis by targeting BCL2.
Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
[TBL] [Abstract][Full Text] [Related]
24. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells.
Zhang C; Fang X; Li W; Shi Q; Wu L; Chen X; Huang Z; Wu P; Wang Z; Liao Z
Cancer Biother Radiopharm; 2014 Dec; 29(10):422-7. PubMed ID: 25405832
[TBL] [Abstract][Full Text] [Related]
25. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
26. Quercetin shortened survival of radio-resistant B-1 cells
Ramos YAL; Souza OF; Novo MCT; Guimarães CFC; Popi AF
Oncotarget; 2021 Feb; 12(4):355-365. PubMed ID: 33659046
[TBL] [Abstract][Full Text] [Related]
27. Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.
Yuan Y; Kasar S; Underbayev C; Vollenweider D; Salerno E; Kotenko SV; Raveche E
Mol Immunol; 2012 Sep; 52(2):61-70. PubMed ID: 22578383
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
29. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
30. Chronic lymphocytic leukemia: molecular genetics and animal models.
Pekarsky Y; Calin GA; Aqeilan R
Curr Top Microbiol Immunol; 2005; 294():51-70. PubMed ID: 16323427
[TBL] [Abstract][Full Text] [Related]
31. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
32. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
[TBL] [Abstract][Full Text] [Related]
33. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
34. MiR-15a and miR-16-1 cluster functions in human leukemia.
Calin GA; Cimmino A; Fabbri M; Ferracin M; Wojcik SE; Shimizu M; Taccioli C; Zanesi N; Garzon R; Aqeilan RI; Alder H; Volinia S; Rassenti L; Liu X; Liu CG; Kipps TJ; Negrini M; Croce CM
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5166-71. PubMed ID: 18362358
[TBL] [Abstract][Full Text] [Related]
35. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
[TBL] [Abstract][Full Text] [Related]
36. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
37. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
[TBL] [Abstract][Full Text] [Related]
38. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
Huang H; Zhang C; Wang B; Wang F; Pei B; Cheng C; Yang W; Zhao Z
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997205
[TBL] [Abstract][Full Text] [Related]
39. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
40. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
